Androgen deprivation therapy linked to cardiovascular risk

19 Oct 2017


A new study in the British Journal of Cancers suggests reports that the therapeutic strategy, commonly used to treat prostate cancer, may result in an increase of cardiovascular disease.

Medical News Today


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story